Search Results
Nov 07, 2025, 11:30 ET Akeso Unveils Promising Preclinical Data for IL-1RAP Targeting Antibody (AK135) at SITC 2025
mechanical allodynia, with a dose-dependent efficacy. Throughout the treatment period, mice in all dose groups maintained stable body weight, with no significant signs of toxicity, demonstrating good tolerance. CIPN is a prevalent and dose-limiting
More news about: Akeso, Inc.
Nov 07, 2025, 10:00 ET InventHelp Inventor Develops Portable Strength Training Equipment (CHK-2250)
The invention provides a portable piece of strength training equipment for fitness enthusiasts. In doing so, it allows for an effective upper-body strength-training workout. It also offers a space-saving alternative to dip and pull-up towers, home gym systems, and other such fitness equipment.
More news about: InventHelp
Nov 07, 2025, 09:39 ET Pro Wrestling League Returns in 2026 to Transform Indian Wrestling
About WFI: The Wrestling Federation of India (WFI) is the apex body governing wrestling in India, affiliated with the Indian Olympic Association and United World Wrestling. About
More news about: Pro Wrestling League (PWL)
Nov 07, 2025, 09:31 ET Pro Wrestling League Returns in 2026 to Transform Indian Wrestling
About WFI: The Wrestling Federation of India (WFI) is the apex body governing wrestling in India, affiliated with the Indian Olympic Association and United World Wrestling. About
More news about: Pro Wrestling League (PWL)
Nov 07, 2025, 09:24 ET DeepL CEO joins German Federal Chancellor's Strategy Group for Technology and Innovation
CEO, Jarek Kutylowski, in the German Federal Chancellor's Strategy Group for Technology and Innovation. This strategy group is the highest advisory body on technology and innovation to the Chancellery.
More news about: DeepL
Nov 07, 2025, 09:00 ET CREATE Medicines Announces Positive First-in-Human Results for MT-302
highly encouraging in tumor settings where immune infiltration has been historically limited. Seeing immune cells effectively reprogrammed inside the body to mount a targeted anti-tumor response represents a meaningful milestone and supports continued clinical advancement."
More news about: CREATE Medicines, Inc.
Nov 07, 2025, 08:39 ET DeepL CEO joins German Federal Chancellor's Strategy Group for Technology and Innovation
CEO, Jarek Kutylowski, in the German Federal Chancellor's Strategy Group for Technology and Innovation. This strategy group is the highest advisory body on technology and innovation to the Chancellery.
More news about: DeepL
Nov 07, 2025, 08:31 ET MetaVia Presents Positive New Phase 2a Data on Vanoglipel (DA-1241) in Patients with Presumed MASH at the AASLD The Liver Meeting® 2025
gut hormone that activates GLP1R and GCGR, thereby decreasing food intake while increasing energy expenditure, thus potentially resulting in superior body weight loss compared to selective GLP1R agonists. In a Phase 1 multiple ascending dose (MAD) trial in obesity, DA-1726 demonstrated best-in-class potential
More news about: MetaVia Inc.
Nov 07, 2025, 08:00 ET Brunswick Collision Center Opens Its Doors to the Community
Specializing in collision repair and auto body services, Brunswick Collision Center also assists clients in navigating insurance claims, making a stressful process smoother and more transparent.
More news about: Brunswick Main Street
Nov 07, 2025, 07:50 ET Alonzo Mourning Shares His Journey to Raise Awareness for Kidney Disease
Summer Olympics in Sydney," he said. "Coming back home, I began to notice troubling symptoms, extreme tiredness, and alarming swelling throughout my body." After a successful kidney transplant from his cousin in 2003, Mourning made a historic return to the NBA, ultimately winning
More news about: Mediaplanet
Nov 07, 2025, 07:00 ET Gundry MD Launches the Total Body Transformation Course: A Breakthrough Weight Loss Program to Help People Look and Feel Years Younger
and regenerative medical practitioner, the Gundry MD team created the Total Body Transformation Plan to make the science of longevity accessible to everyone. Inside the Total Body Transformation PlanThe program is a 13-week guided video series
More news about: Gundry MD
Nov 07, 2025, 07:00 ET Alebund Presents Phase 3 Trial Results of AP301 at the American Society of Nephrology (ASN) 2025 Congress
the patients' outcome. For CKD patients undergoing dialysis treatment, regular dialysis is not sufficient to remove the excess serum phosphate in the body. Considering the limitations of low-phosphate diet which might cause dystrophia, oral use of phosphate binders is the prevailing treatment for hyperphosphatemia.
More news about: Alebund Pharmaceuticals
Nov 07, 2025, 06:57 ET GORE ANNOUNCES POSITIVE CLINICAL TRIAL RESULTS OF THE INVESTIGATIONAL GORE® VIABAHN® FORTEGRA VENOUS STENT FOR TREATMENT OF PATIENTS WITH DEEP VENOUS ILIOCAVAL OBSTRUCTION
has solved complex technical challenges in demanding environments—from outer space to the world's highest peaks to the inner workings of the human body. With approximately 13,000 Associates and a strong, team-oriented culture, Gore generates annual revenues of $5 billion. gore.com
More news about: W. L. Gore & Associates, Inc. MPD Division
Nov 07, 2025, 04:30 ET LEPAS Elegant Technology Safeguards Every Elegant Journey with Global Five-Star Safety Standards
In body-structure safety, Elegant Technology establishes a formidable protective barrier. The vehicle adopts a three-path front impact design and an 8-longitudinal, 5-transverse floor layout to efficiently disperse energy and preserve cabin integrity. The body structure uses 75% high-strength
More news about: Chery Group
Nov 07, 2025, 03:47 ET LEPAS Elegant Technology Safeguards Every Elegant Journey with Global Five-Star Safety Standards
In body-structure safety, Elegant Technology establishes a formidable protective barrier. The vehicle adopts a three-path front impact design and an 8-longitudinal, 5-transverse floor layout to efficiently disperse energy and preserve cabin integrity. The body structure uses 75% high-strength
More news about: Chery Group
Nov 07, 2025, 03:00 ET Geely Auto's game-changing Geely EX2 arrives to redefine the city car standard
structure, and a real-time temperature monitoring system. In terms of structural safety, the Geely EX2 features reinforced cabin structures, including a cage body and a #-shaped rear subframe, as well as a tri-directional energy-absorbing structure to enhance structural integrity in various conditions.
More news about: Geely Auto
Nov 06, 2025, 21:00 ET Argo Biopharma to Present Positive Phase I Results of siRNA Therapeutic BW-20805 for HAE at ACAAI 2025
Hereditary angioedema (HAE) is a rare genetic condition that causes sudden and unpredictable swelling in different parts of the body. In severe cases, it can affect the throat and become life-threatening, with a mortality rate of up to 40%.1 HAE affects about 1.5 people
More news about: Argo Biopharmaceutical Co., Ltd
Nov 06, 2025, 18:09 ET Pilates Addiction Surpasses 150 Territories - Growth Shows No Signs of Slowing
WundaFormer – considered the Swiss Army knife of Pilates. Combining reformer, jump board, ballet barre, and Wunda Chair, it powers high-intensity, full-body workouts that keep clients coming back. Sarah Luna, CEO of Pilates Addiction, said: "We've created a brand that is modern, aspirational,
More news about: Pilates Addiction
Nov 06, 2025, 17:07 ET DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma
Monitor patients with neutropenia for signs of infection. Consider withholding DARZALEX FASPRO® until recovery of neutrophils. In lower body weight patients receiving DARZALEX FASPRO®, higher rates of Grade 3-4 neutropenia were observed.
More news about: Johnson & Johnson
Nov 06, 2025, 16:16 ET Tharimmune, Inc. Closes $545 Million Private Placement to Establish Canton Coin Treasury Strategy
Nima Capital, Obsidian Software, Polychain Capital, Proof Group, SBI Group, The Tie, Tradeweb Markets, and 7RIDGE. The Canton Foundation, the governing body overseeing the Canton Network, also participated, making Tharimmune the first and only publicly traded company supported by the Canton Foundation.
More news about: Tharimmune, Inc.
Nov 06, 2025, 16:05 ET Natural Grocers by Vitamin Cottage, Inc. Announces Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast
Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) is an expanding specialty retailer of natural and organic groceries, body care products and dietary supplements. The grocery products sold by Natural Grocers must meet strict quality guidelines and may not contain artificial
More news about: Natural Grocers by Vitamin Cottage, Inc.
Nov 06, 2025, 16:05 ET FLOWERS FOODS, INC. REPORTS THIRD QUARTER 2025 RESULTS
(l) disruptions in our direct-store-delivery distribution model, including litigation or an adverse ruling by a court or regulatory or governmental body that could affect the independent contractor classifications of the independent distributor partners ("IDPs"), and changes to our direct-store-delivery
More news about: Flowers Foods, Inc.
Nov 06, 2025, 14:30 ET Novo Nordisk's CagriSema was associated with significant reduction in blood pressure and showed anti-inflammatory effects while reducing the proportion of patients at risk of developing heart disease over time in new analyses at ObesityWeek®
obesity-related health issues like cardiovascular disease." CagriSema was also associated with a reduction in a key marker of body-wide inflammation – high-sensitivity C-reactive protein (hsCRP) – at week 68, regardless of baseline hsCRP levels. The reduction with CagriSema (–68.9%)
More news about: NOVO NORDISK INC.
Nov 06, 2025, 14:30 ET Novo Nordisk's CagriSema was associated with significant reduction in blood pressure and showed anti-inflammatory effects while reducing the proportion of patients at risk of developing heart disease over time in new analyses at ObesityWeek®
obesity-related health issues like cardiovascular disease." CagriSema was also associated with a reduction in a key marker of body-wide inflammation – high-sensitivity C-reactive protein (hsCRP) – at week 68, regardless of baseline hsCRP levels. The reduction with CagriSema (–68.9%)
More news about: NOVO NORDISK INC.
Nov 06, 2025, 14:22 ET Sandbox VR Opened First Bavaria Location on October 9
where players can move freely, communicate naturally, and physically interact within fully immersive digital worlds. Outfitted with VR headsets, full-body tracking, haptic vests, and sensors, groups of up to six can step directly into thrilling universes crafted by Sandbox VR's own game studio. From sci-fi
More news about: Sandbox VR